✦ LIBER ✦

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study

✍ Scribed by Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; Robert L. DeBernardo; Robert S. Mannel; Eric L. Eisenhauer; Linda R. Duska; Paula M. Fracasso

Book ID: 113963322
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 162 KB
Volume: 123
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.07.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Mark A. Morgan; Michael W. Sill; Keiichi Fujiwara; Benjamin Greer; Stephen C. Ru 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; Premal H. Thaker; Paul A. DiSi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II trial of intraperitoneal cispla

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

✍ Lisa M. Landrum; Johnny Hyde Jr.; Robert S. Mannel; D. Scott McMeekin; Kathleen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Progression-free and overall survival of

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer

✍ Joyce N. Barlin; Fanny Dao; Nadim Bou Zgheib; Sarah E. Ferguson; Paul J. Sabbati 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A Phase II Study of Intraperitoneal Cisp

A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study

✍ Lynn G. Feun; John A. Blessing; Francis J. Major; Philip J. DiSaia; Ronald D. Al 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 77 KB